Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
about
Antipsychotic dosing: found in translationDefinitions and drivers of relapse in patients with schizophrenia: a systematic literature reviewPredictors of switching antipsychotic medications in the treatment of schizophreniaEffectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysisHealth-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database.Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use.An investigation of economic costs of schizophrenia in two areas of China.Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs.Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness
P2860
Q26863343-8B66D51D-A34F-451F-ACD1-1DD75FDA3654Q33589087-8340A29F-A859-44E0-9874-F4034C8E5B8EQ33709704-90FC4DE9-7038-4770-88B9-443D6BDDB8BCQ34073723-172E3AEA-E02B-4EBE-B518-DAADCE666CF2Q34640811-45523CCD-C64A-4087-9EC2-A1C288E92536Q34653803-0E4E2C63-1E58-4F1F-AD8C-8F598553E487Q34982167-5BC26997-C8F9-4F28-B90C-CB5E6C400F17Q35100117-36B8A8C2-1796-4AA5-8CF2-F52EDDF9B893Q35249595-224330DF-A979-4123-AF93-69E060B1A384Q35948858-85C928F8-8F8C-4498-B290-FEF13CA04D58Q37350099-89C2C2AE-9043-4F9D-8F57-205BF923BE9DQ37822216-8407CC6E-9734-4085-A004-B9B2942F8704Q57484956-47F9FFC2-9330-40BB-B080-B9DE33A81FEB
P2860
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Clinical and economic ramifica ...... the treatment of schizophrenia
@ast
Clinical and economic ramifica ...... the treatment of schizophrenia
@en
type
label
Clinical and economic ramifica ...... the treatment of schizophrenia
@ast
Clinical and economic ramifica ...... the treatment of schizophrenia
@en
prefLabel
Clinical and economic ramifica ...... the treatment of schizophrenia
@ast
Clinical and economic ramifica ...... the treatment of schizophrenia
@en
P2093
P2860
P356
P1433
P1476
Clinical and economic ramifica ...... the treatment of schizophrenia
@en
P2093
Allen W Nyhuis
Bruce J Kinon
Douglas E Faries
P2860
P2888
P356
10.1186/1471-244X-9-54
P577
2009-09-02T00:00:00Z
P6179
1038200811